Literature DB >> 8832640

Diffuse plaques contain C-terminal A beta 42 and not A beta 40: evidence from cats and dogs.

B J Cummings1, T Satou, E Head, N W Milgram, G M Cole, M J Savage, M B Podlisny, D J Selkoe, R Siman, B D Greenberg, C W Cotman.   

Abstract

Recent reports have suggested that beta-amyloid (A beta) species of variable length C-termini are differentially deposited within early and late-stage plaques and the cerebrovasculature. Specifically, longer C-terminal length A beta 42/3 fragments (i.e., A beta forms extending to residues 42 and/or 43) are thought to be predominant within diffuse plaques while both A beta 42/3 and A beta 40 (A beta forms terminating at residue 40) are present within a subset of neuritic plaques and cerebrovascular deposits. We sought to clarify the issue of differential A beta deposition using aged canines, a partial animal model of Alzheimer's disease that exhibits extensive diffuse plaques and frequent vascular amyloid, but does not contain neuritic plaques or neurofibrillary tangles. We examined the brains of 20 aged canines, 3 aged felines, and 17 humans for the presence of A beta immunoreactive plaques, using antibodies to A beta 1(-17), A beta 17(-24), A beta 1(-28), A beta 40, and A beta 42. We report that plaques within the canine and feline brain are immunopositive for A beta 42 but not A beta 40. This is the first observation of nascent AD pathology in the aged feline brain. Canine plaques also contained epitopes within A beta 1(-17), A beta 17(-24), and A beta 1(-28). In all species examined, vascular deposits were immunopositive for both A beta 40 and A beta 42. In the human brain, diffuse plaques were preferentially A beta 42 immunopositive, while neuritic plaques and vascular deposits were both A beta 40 and A beta 42 immunopositive. However, not all neuritic plaques contain A beta 40 epitopes.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8832640     DOI: 10.1016/0197-4580(96)00062-0

Source DB:  PubMed          Journal:  Neurobiol Aging        ISSN: 0197-4580            Impact factor:   4.673


  27 in total

1.  Aβ aggregation profiles and shifts in APP processing favor amyloidogenesis in canines.

Authors:  Viorela Pop; Elizabeth Head; Nicole C Berchtold; Charles G Glabe; Christa M Studzinski; Adam M Weidner; M Paul Murphy; Carl W Cotman
Journal:  Neurobiol Aging       Date:  2010-04-30       Impact factor: 4.673

2.  BDNF increases with behavioral enrichment and an antioxidant diet in the aged dog.

Authors:  Margaret Fahnestock; Monica Marchese; Elizabeth Head; Viorela Pop; Bernadeta Michalski; William N Milgram; Carl W Cotman
Journal:  Neurobiol Aging       Date:  2010-05-05       Impact factor: 4.673

3.  Rhinal and dorsolateral prefrontal cortex lesions produce selective impairments in object and spatial learning and memory in canines.

Authors:  Lori-Ann Christie; Richard C Saunders; Danuta M Kowalska; William A MacKay; Elizabeth Head; Carl W Cotman
Journal:  J Comp Neurol       Date:  2008-11-10       Impact factor: 3.215

4.  Improvement of short-term memory performance in aged beagles by a nutraceutical supplement containing phosphatidylserine, Ginkgo biloba, vitamin E, and pyridoxine.

Authors:  Joseph A Araujo; Gary M Landsberg; Norton W Milgram; Alda Miolo
Journal:  Can Vet J       Date:  2008-04       Impact factor: 1.008

5.  Beta-amyloid deposition in chronic traumatic encephalopathy.

Authors:  Thor D Stein; Philip H Montenigro; Victor E Alvarez; Weiming Xia; John F Crary; Yorghos Tripodis; Daniel H Daneshvar; Jesse Mez; Todd Solomon; Gaoyuan Meng; Caroline A Kubilus; Kerry A Cormier; Steven Meng; Katharine Babcock; Patrick Kiernan; Lauren Murphy; Christopher J Nowinski; Brett Martin; Diane Dixon; Robert A Stern; Robert C Cantu; Neil W Kowall; Ann C McKee
Journal:  Acta Neuropathol       Date:  2015-05-06       Impact factor: 17.088

6.  Na,K-ATPase mRNA levels and plaque load in Alzheimer's disease.

Authors:  N B Chauhan; J M Lee; G J Siegel
Journal:  J Mol Neurosci       Date:  1997-12       Impact factor: 3.444

Review 7.  Aging in the canine and feline brain.

Authors:  Charles H Vite; Elizabeth Head
Journal:  Vet Clin North Am Small Anim Pract       Date:  2014-11-01       Impact factor: 2.093

8.  Assessment of nutritional interventions for modification of age-associated cognitive decline using a canine model of human aging.

Authors:  Joseph A Araujo; Christa M Studzinski; Elizabeth Head; Carl W Cotman; Norton W Milgram
Journal:  Age (Dordr)       Date:  2005-05-02

9.  Amyloid precursor protein-mediated endocytic pathway disruption induces axonal dysfunction and neurodegeneration.

Authors:  Wei Xu; April M Weissmiller; Joseph A White; Fang Fang; Xinyi Wang; Yiwen Wu; Matthew L Pearn; Xiaobei Zhao; Mariko Sawa; Shengdi Chen; Shermali Gunawardena; Jianqing Ding; William C Mobley; Chengbiao Wu
Journal:  J Clin Invest       Date:  2016-04-11       Impact factor: 14.808

Review 10.  Alzheimer's disease and the amyloid-beta peptide.

Authors:  M Paul Murphy; Harry LeVine
Journal:  J Alzheimers Dis       Date:  2010       Impact factor: 4.472

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.